
|Articles|July 1, 2003
Itch Treatments
San Francisco - A better understanding of the pathophysiologic mediators of itch has led to some novel and promising approaches to its successful treatment, Gil Yosipovitch, M.D., said at the annual meeting of the American Academy of Dermatology. Several exciting systemic therapies approved for the treatment of various neurologically mediated disorders now show potential in the treatment of itch.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
AbbVie Files for Vitiligo Indication, Putting Systemic Therapy Under Regulatory Review
2
Nutrafol Expands Portfolio with First and Only Hair Loss Supplement for Male Patients 50 and Older
3
Icotrokinra Shows Superior Efficacy Over Advanced Oral Therapies in New Psoriasis Meta-Analysis
4
Introducing Dermatology Times NP/PA Connect
5











